Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Gilead is charging Americans with non-Hodgkin’s lymphoma $424,000 for Yescarta – a therapy that can be purchased in Japan for just $212,000.
Simplified Text
Gilead charges Americans $424000 for Yescarta. Yescarta costs $212000 in Japan.
Confidence Score
0.500
Claim Maker
Bernie Sanders
Context Type
Website Article
Context Details
{
    "date": null
}
Subject Tags
UUID
9fdb2e70-d37f-4af0-b529-98dd4290cf7c
Vector Index
✗ No vector
Created
September 12, 2025 at 12:34 AM (11 hours ago)
Last Updated
September 12, 2025 at 12:34 AM (11 hours ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.sanders.senate.gov/op-eds/the-greed-of-big-pharma-cannot-continue/
44 claims 🔥
11 hours ago
https://www.sanders.senate.gov/op-eds/the-greed-of-big-pharma-cannot-continue/

Senator Sanders criticizes exorbitant prescription drug prices in the US, highlighting the industry's lobbying power and advocating for price controls.

Pharmaceutical Industry
Healthcare Costs
Drug Pricing
Lobbying
US Politics
Medicare

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP